O-GlcNAcylation in cancer biology: linking metabolism and signaling
CM Ferrer, VL Sodi, MJ Reginato - Journal of molecular biology, 2016 - Elsevier
The hexosamine biosynthetic pathway (HBP) is highly dependent on multiple metabolic
nutrients including glucose, glutamine, and acetyl-CoA. Increased flux through HBP leads to …
nutrients including glucose, glutamine, and acetyl-CoA. Increased flux through HBP leads to …
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Transcription factors (TFs) are indispensable for the modulation of various signaling
pathways associated with normal cell homeostasis and disease conditions. Among cancer …
pathways associated with normal cell homeostasis and disease conditions. Among cancer …
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy
A Aytes, A Mitrofanova, C Lefebvre, MJ Alvarez… - Cancer cell, 2014 - cell.com
To identify regulatory drivers of prostate cancer malignancy, we have assembled genome-
wide regulatory networks (interactomes) for human and mouse prostate cancer from …
wide regulatory networks (interactomes) for human and mouse prostate cancer from …
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
HB Ragnum, L Vlatkovic, AK Lie, K Axcrona… - British journal of …, 2015 - nature.com
Background: The hypoxia marker pimonidazole is a candidate biomarker of cancer
aggressiveness. We investigated the transcriptional programme associated with …
aggressiveness. We investigated the transcriptional programme associated with …
FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence
Aneuploidy, an abnormal chromosome number, has been linked to aging and age-
associated diseases, but the underlying molecular mechanisms remain unknown. Here we …
associated diseases, but the underlying molecular mechanisms remain unknown. Here we …
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis
S Shen, J Kong, Y Qiu, X Yang… - Journal of cellular …, 2019 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the most common malignant liver disease in the world.
However, the mechanistic relationships among various genes and signaling pathways are …
However, the mechanistic relationships among various genes and signaling pathways are …
FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch in myofibroblasts
M Black, D Milewski, T Le, X Ren, Y Xu… - Cell reports, 2018 - cell.com
Idiopathic pulmonary fibrosis (IPF) is characterized by aberrant accumulation of collagen-
secreting myofibroblasts. Development of effective therapies is limited due to incomplete …
secreting myofibroblasts. Development of effective therapies is limited due to incomplete …
SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene
XH Cheng, M Black, V Ustiyan, T Le, L Fulford… - PLoS …, 2014 - journals.plos.org
SAM-pointed domain-containing ETS transcription factor (SPDEF) is expressed in normal
prostate epithelium. While its expression changes during prostate carcinogenesis (PCa), the …
prostate epithelium. While its expression changes during prostate carcinogenesis (PCa), the …
FOXF1 maintains endothelial barrier function and prevents edema after lung injury
Multiple signaling pathways, structural proteins, and transcription factors are involved in the
regulation of endothelial barrier function. The forkhead protein FOXF1 is a key …
regulation of endothelial barrier function. The forkhead protein FOXF1 is a key …
Oncogenic role of FOXM1 in human prostate cancer
DY Lee, JN Chun, I So, JH Jeon - Oncology Reports, 2023 - spandidos-publications.com
Prostate cancer is the leading cause of cancer-related mortality among men worldwide. In
particular, castration-resistant prostate cancer presents a formidable clinical challenge and …
particular, castration-resistant prostate cancer presents a formidable clinical challenge and …